Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eran Atlas

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Diabetes Care|August 1, 2014
MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trialRevital Nimri, Ido Muller, Eran Atlas, et al.
Pediatric Diabetes|March 2, 2013
The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trialRevital Nimri, Thomas Danne, Olga Kordonouri, et al.
Pediatric Diabetes|August 16, 2013
Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysisRevital Nimri, Ido Muller, Eran Atlas, et al.
The New England Journal of Medicine|March 1, 2013
Nocturnal glucose control with an artificial pancreas at a diabetes campMoshe Phillip, Tadej Battelino, Eran Atlas, et al.
Diabetes Technology & Therapeutics|November 13, 2020
Feasibility Study of a Hybrid Closed-Loop System with Automated Insulin Correction BolusesRevital Nimri, Benyamin Grosman, Anirban Roy, et al.
Diabetologia|August 26, 2017
Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trialKlemen Dovc, Maddalena Macedoni, Natasa Bratina, et al.
Diabetes Care|November 30, 2012
Clinical evaluation of a personalized artificial pancreasEyal Dassau, Howard Zisser, Rebecca A Harvey, et al.
Diabetes, Obesity & Metabolism|November 20, 2020
Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream studyTorben Biester, Ido Muller, Thekla von dem Berge, et al.
Diabetes, Obesity & Metabolism|December 17, 2016
MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trialRevital Nimri, Natasa Bratina, Olga Kordonouri, et al.
Diabetes, Obesity & Metabolism|November 28, 2018
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at homeTorben Biester, Judith Nir, Kerstin Remus, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Diabetes Care|August 1, 2014
MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trialRevital Nimri, Ido Muller, Eran Atlas, et al.
Pediatric Diabetes|March 2, 2013
The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trialRevital Nimri, Thomas Danne, Olga Kordonouri, et al.
Pediatric Diabetes|August 16, 2013
Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysisRevital Nimri, Ido Muller, Eran Atlas, et al.
The New England Journal of Medicine|March 1, 2013
Nocturnal glucose control with an artificial pancreas at a diabetes campMoshe Phillip, Tadej Battelino, Eran Atlas, et al.
Diabetes Technology & Therapeutics|November 13, 2020
Feasibility Study of a Hybrid Closed-Loop System with Automated Insulin Correction BolusesRevital Nimri, Benyamin Grosman, Anirban Roy, et al.
Diabetologia|August 26, 2017
Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trialKlemen Dovc, Maddalena Macedoni, Natasa Bratina, et al.
Diabetes Care|November 30, 2012
Clinical evaluation of a personalized artificial pancreasEyal Dassau, Howard Zisser, Rebecca A Harvey, et al.
Diabetes, Obesity & Metabolism|November 20, 2020
Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream studyTorben Biester, Ido Muller, Thekla von dem Berge, et al.
Diabetes, Obesity & Metabolism|December 17, 2016
MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trialRevital Nimri, Natasa Bratina, Olga Kordonouri, et al.
Diabetes, Obesity & Metabolism|November 28, 2018
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at homeTorben Biester, Judith Nir, Kerstin Remus, et al.
Pageof 3